The DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
Sertraline versus other antidepressive agents for depression
Open accessAbstract
BACKGROUND: Mirtazapine has a unique mechanism of antidepressive action and is one of the commonly used antidepressants in clinical practice. OBJECTIVES: The aim of the present review was to assess the evidence on the efficacy and acceptability of mirtazapine compared with other antidepressive agents in the acute-phase treatment of major depression in adults. SEARCH METHODS: We searched the Cochrane Collaboration Depression, Anxiety and Neurosis review group's specialised register (CCDANCTR), which includes relevant randomised controlled trials from the following bibliographic databases: The Cochrane Library (all years to April 2011), EMBASE, (1980 to July 2011) MEDLINE (1950 to July 2011) and PsycINFO (1974 to July 2011). Reference lists of the reports of relevant studies were checked and experts in the field contacted. The review was not limited to English-language articles. SELECTION CRITERIA: Randomised controlled trials (RCTs) allocating participants with major depression to mirtazapine versus any other antidepressive agent. DATA COLLECTION AND ANALYSIS: Two authors independently checked eligibility and extracted data on an intention-to-treat basis. The primary outcome was response to treatment. The secondary outcomes included dropouts and individual adverse events.Meta-analyses were conducted using the random-effects model. MAIN RESULTS: A total of 29 RCTs (n = 4974), mostly following up the participants for six weeks in outpatient clinics and inadequately reporting the risk of bias, were included. In comparison with tricyclic antidepressants (10 trials, n = 1553) there was no robust evidence to detect a difference between mirtazapine and tricyclics in terms of response at two weeks (odds ratio (OR) 0.85, 95% confidence interval (CI) 0.64 to 1.13) or at the end of acute-phase treatment (at 6 to 12 weeks) (OR 0.89, 95% CI 0.72 to 1.10). In comparison with selective serotonin reuptake inhibitors (SSRIs) (12 trials, n = 2626) mirtazapine was significantly more effective at two weeks (OR 1.57, 95% CI 1.30 to 1.88) and at the end of acute-phase treatment (OR 1.19, 95% CI 1.01 to 1.39). Mirtazapine was significantly more effective than a serotonin-noradrenaline reuptake inhibitor (venlafaxine only, two trials, n = 415) at two weeks (OR 2.29, 95% CI 1.45 to 3.59) and at the end of acute-phase treatment (OR 1.53, 95% CI 1.03 to 2.25).In terms of dropouts, there was no robust evidence to detect a difference between mirtazapine and other antidepressants. Mirtazapine was more likely to cause weight gain or increased appetite and somnolence than SSRIs but less likely to cause nausea or vomiting and sexual dysfunction. AUTHORS' CONCLUSIONS: Some statistically significant and possibly clinically meaningful differences between mirtazapine and other antidepressive agents were found for the acute-phase treatment of major depression. Mirtazapine is likely to have a faster onset of action than SSRIs during the acute-phase treatment. Dropouts occur similarly in participants treated with mirtazapine and those treated with other antidepressants, although the adverse event profile of mirtazapine is unique.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Barbui, C., Hotopf, M. H., Freemantle, N., Boynton, J. R., Churchill, R. C., Eccles, M., Geddes, J. R., Hardy, R., Lewis, G., & Mason, J. M. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002791 · Cited by 87
Self-citationRetractedDiagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
SF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Diagnostic Criteria for Use in Psychiatric Research
Feighner, J. P. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750190059011 · Cited by 5,715
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
The Whoqol Group (1998) · Social Science & Medicine · doi:10.1016/s0277-9536(98)00009-4 · Cited by 3,802
The world health report 2001 - Mental health: new understanding, new hope
Sayers, J. G. (2001) · Europe PMC (PubMed Central) · doi:10.1590/s0042-96862001001100014 · Cited by 3,123
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147
Bucher, H. C., Guyatt, G. H., Griffith, L. E., & Walter, S. D. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00049-8 · Cited by 2,052
Chan, A.-W., Hróbjartsson, A., Haahr, M. T., Gøtzsche, P. C., & Altman, D. G. (2004) · JAMA · doi:10.1001/jama.291.20.2457 · Cited by 1,845
Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R)
Spitzer, R. L., & Williams, J. (1987) · Cited by 1,823
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Self-citationImputing missing standard deviations in meta-analyses can provide accurate results
Furukawa, T. A., Barbui, C., Cipriani, A., Brambilla, P., & Watanabe, N. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.06.006 · Cited by 1,568
Self-citationSertraline treatment of major depression in patients with acute MI or unstable angina
Glassman, A. H. (2002) · JAMA · doi:10.1001/jama.288.6.701 · Cited by 1,414
The Economic Burden of Depression in the United States: How Did It Change Between 1990 and 2000?
Greenberg, P. E., Kessler, R. C., Birnbaum, H. G., Leong, S. A., Lowe, S. W., Berglund, P. A., & Corey-Lisle, P. K. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1211 · Cited by 1,280
Statistics Notes: Detecting skewness from summary information: Table 1
Altman, D. G., & Bland, J. M. (1996) · BMJ · doi:10.1136/bmj.313.7066.1200 · Cited by 1,278
Network meta‐analysis for indirect treatment comparisons
Lumley, T. (2002) · Statistics in Medicine · doi:10.1002/sim.1201 · Cited by 1,206
Evaluation of networks of randomized trials
Salanti, G., Higgins, J. P., Ades, A., & Ioannidis, J. P. (2008) · Statistical Methods in Medical Research · doi:10.1177/0962280207080643 · Cited by 1,078
Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., & Boddington, E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16043-1 · Cited by 1,058
Distributed Disturbances in Brain Structure and Function in Schizophrenia
(2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.1 · Cited by 969
Song, F., Altman, D. G., Glenny, A.-M., & Deeks, J. J. (2003) · BMJ · doi:10.1136/bmj.326.7387.472 · Cited by 943
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
A consumer's guide to subgroup analyses
Oxman, A. D., & Guyatt, G. H. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-78 · Cited by 914
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
A Review of the Pharmacological and Clinical Profile of Mirtazapine
Anttila, S. A. K., & Leinonen, E. V. J. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00198.x · Cited by 795
Assessing Evidence Inconsistency in Mixed Treatment Comparisons
Lu, G., & Ades, A. E. (2006) · Journal of the American Statistical Association · doi:10.1198/016214505000001302 · Cited by 756
Als-Nielsen, B., Chen, W., Gluud, C., & Kjaergard, L. L. (2003) · JAMA · doi:10.1001/jama.290.7.921 · Cited by 746
Lespérance, F., Frasure-Smith, N., Koszycki, D., Laliberté, M.-A., van Zyl, L. T., Baker, B., Swenson, J. R., Ghatavi, K., Abramson, B. L., Dorian, P., et al. (2007) · JAMA · doi:10.1001/jama.297.4.367 · Cited by 658
Comparative responsiveness of generic and specific quality-of-life instruments
Wiebe, S., Guyatt, G., Weaver, B., Matijevic, S., & Sidwell, C. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00537-1 · Cited by 573
Bhandari, M., Busse, J. W., Jackowski, D., Montori, V. M., Schünemann, H. J., Sprague, S., Mears, D., Schemitsch, E. H., Heels-Ansdell, D., & Devereaux, P. J. (2004) · Europe PMC (PubMed Central) · Cited by 551
Prevalence of Sexual Dysfunction Among Newer Antidepressants
Clayton, A. H., Pradko, J. F., Croft, H. A., Montano, C. B., Leadbetter, R. A., Bolden-Watson, C., Bass, K. I., Donahue, R. M. J., Jamerson, B. D., & Metz, A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0414 · Cited by 542
Smith, D., Dempster, C., Glanville, J., Freemantle, N., & Anderson, I. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.5.396 · Cited by 538
Hypericum Depression Trial Study Group (2002) · JAMA · doi:10.1001/jama.287.14.1807 · Cited by 480
St John's wort for major depression
Linde, K., Berner, M. M., & Kriston, L. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000448.pub3 · Cited by 477
Awareness, diagnosis, and treatment of depression
the Council on Scientific Affairs, A. M. A., Goldman, L. S., Nielsen, N. H., & Champion, H. C. (1999) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1999.03478.x · Cited by 466
Clinicians' Judgments of Mental Health: A Proposed Scale
LUBORSKY, L. (1962) · Archives of General Psychiatry · doi:10.1001/archpsyc.1962.01720060019002 · Cited by 459
Williams, J. W., Mulrow, C. D., Chiquette, E., Noël, P. H., Aguilar, C., & Cornell, J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-9-200005020-00011 · Cited by 423
Fava, M., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Alpert, J. E., McGrath, P. J., Thase, M. E., Warden, D., Biggs, M., Luther, J. F., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.7.1161 · Cited by 362
Rush, A. J. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.2.201 · Cited by 353
Arroll, B. (2005) · The Annals of Family Medicine · doi:10.1370/afm.349 · Cited by 351
Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients.
Cohn, C. K., Shrivastava, R., Mendels, J., Cohn, J. B., Fabre, L. F., Claghorn, J. L., Dessain, E. C., Itil, T. M., & Lautin, A. (1990) · PubMed · Cited by 348
Bauer, M., Whybrow, P. C., Angst, J., Versiani, M., Möller, H.-J., & WFSBP Task Force on Treatment Guide (2002) · The World Journal of Biological Psychiatry · doi:10.3109/15622970209150599 · Cited by 346
Imputing response rates from means and standard deviations in meta-analyses
Furukawa, T. A., Cipriani, A., Barbui, C., Brambilla, P., & Watanabe, N. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200501000-00010 · Cited by 337
Self-citationSNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression
Kent, J. M. (2000) · The Lancet · doi:10.1016/s0140-6736(99)11381-3 · Cited by 329
(1996) · PubMed · Cited by 328
Perlis, R. H., Perlis, C. S., Wu, Y., Hwang, C., Joseph, M., & Nierenberg, A. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1957 · Cited by 318
Furukawa, T. A., Guyatt, G. H., & Griffith, L. E. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.72 · Cited by 318
Self-citationCitalopram versus other anti-depressive agents for depression
Cipriani, A., Purgato, M., Furukawa, T. A., Trespidi, C., Imperadore, G., Signoretti, A., Churchill, R., Watanabe, N., & Barbui, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006534.pub2 · Cited by 311
Self-citationStandardizing the Hamilton Depression Rating Scale: past, present, and future
Williams, J. B. W. (2001) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf03035120 · Cited by 293
Pharmacogenetics of Antidepressant Medication Intolerance
Murphy, G. M., Kremer, C., Rodrigues, H. E., & Schatzberg, A. F. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1830 · Cited by 283
Prevalence, nature, and comorbidity of depressive disorders in primary care
Coyne, J. C., Fechner-Bates, S., & Schwenk, T. L. (1994) · General Hospital Psychiatry · doi:10.1016/0163-8343(94)90006-x · Cited by 281
Murphy, G. M., Hollander, S. B., Rodrigues, H. E., Kremer, C., & Schatzberg, A. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1163 · Cited by 275
Bollini, P., Pampaliona, S., Tibaldi, G., Kupelnick, B., & Munizza, C. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.174.4.297 · Cited by 274
Guaiana, G., Barbui, C., & Hotopf, M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004186.pub2 · Cited by 271
Self-citationFawcett, J., & Barkin, R. L. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0306 · Cited by 266
Reimherr, F. W., Chouinard, G., Cohn, C. K., Cole, J. O., Itil, T. M., LaPierre, Y. D., Masco, H. L., & MENDELS, J. (1990) · PubMed · Cited by 263
Australian and New Zealand Clinical Practice Guidelines for the Treatment of Depression
Royal Australian And New Zealand College Of Psychiatrists Clinical Practice Guidelines Team For Depression (2004) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2004.01377.x · Cited by 257
Koe, B. K., Weissman, A., Welch, W. M., & Browne, R. G. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21773-6 · Cited by 257
Hansen, R. A., Gartlehner, G., Lohr, K. N., Gaynes, B. N., & Carey, T. S. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-6-200509200-00006 · Cited by 255
Fluoxetine versus other types of pharmacotherapy for depression
Magni, L. R., Purgato, M., Gastaldon, C., Papola, D., Furukawa, T. A., Cipriani, A., & Barbui, C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004185.pub3 · Cited by 252
Self-citationCroft, H., Settle, E., Houser, T., Batey, S. R., Donahue, R. M. J., & Ascher, J. A. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)88317-4 · Cited by 242
Gartlehner, G., Gaynes, B. N., Hansen, R. A., Thieda, P., DeVeaugh-Geiss, A., Krebs, E. E., Moore, C. G., Morgan, L., & Lohr, K. N. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-10-200811180-00008 · Cited by 237
Zimmerman, M., Posternak, M. A., & Chelminski, I. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.03.007 · Cited by 229
Frances, R. J. (2007) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)70411-0 · Cited by 220
Double-Blind, Randomized Comparison of Mirtazapine and Paroxetine in Elderly Depressed Patients
Schatzberg, A. F., Kremer, C., Rodrigues, H. E., & Murphy, G. M. (2002) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200209000-00007 · Cited by 215
Fluvoxamine versus other anti-depressive agents for depression
Omori, I. M., Watanabe, N., Nakagawa, A., Cipriani, A., Barbui, C., McGuire, H., Churchill, R., & Furukawa, T. A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006114.pub2 · Cited by 209
Self-citationBondareff, W., Alpert, M., Friedhoff, A. J., Richter, E. M., Clary, C. M., & Batzar, E. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.729 · Cited by 202
Reboxetine: tolerability and safety profile in patients with major depression
Tanum, L. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.02606.x · Cited by 198
The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission
de Boer, T. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199512004-00004 · Cited by 196
Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: A meta-analysis
Steffens, D. C., Krishnan, K. R. R., & Helms, M. J. (1997) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1997)6:1<10::aid-da2>3.0.co;2-9 · Cited by 192
Escitalopram versus other antidepressive agents for depression
Cipriani, A., Santilli, C., Furukawa, T. A., Signoretti, A., Nakagawa, A., McGuire, H., Churchill, R., & Barbui, C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006532.pub2 · Cited by 190
Self-citationFeiger, A. D., Kiev, A., Shrivastava, R. K., Wisselink, P., & Wilcox, C. S. (1996) · PubMed · Cited by 185
Brenner, R., Azbel, V., Madhusoodanan, S., & Pawlowska, M. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)89010-4 · Cited by 176
Expanding the Black Box — Depression, Antidepressants, and the Risk of Suicide
Friedman, R. A., & Leon, A. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmp078015 · Cited by 174
Fluoxetine versus other types of pharmacotherapy for depression
Cipriani, A., Brambilla, P., Furukawa, T. A., Geddes, J. R., Gregis, M., Hotopf, M. H., Malvini, L., & Barbui, C. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004185.pub2 · Cited by 170
Self-citationIssues in the use of change scores in randomized trials
Norman, G. R. (1989) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(89)90051-6 · Cited by 168
The economic burden of depression in the US: societal and patient perspectives
Greenberg, P. E., & Birnbaum, H. G. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.3.369 · Cited by 166
Winokur, A., DeMartinis, N. A., McNally, D. P., Gary, E. M., Cormier, J. L., & Gary, K. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1013 · Cited by 165
Duloxetine versus other anti-depressive agents for depression
Cipriani, A., Koesters, M., Furukawa, T. A., Nosè, M., Purgato, M., Omori, I. M., Trespidi, C., & Barbui, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006533.pub2 · Cited by 165
Self-citationLawrenson, R., Tyrer, F., Newson, R. B., & Farmer, R. D. T. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00147-0 · Cited by 165
A Double-Blind Comparison of Sertraline and Fluoxetine in Depressed Elderly Outpatients
Newhouse, P. A., Krishnan, K. R. R., Doraiswamy, P. M., Richter, E. M., Batzar, E. D., & Clary, C. M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0804 · Cited by 163
Blier, P., Gobbi, G., Turcotte, J. E., de Montigny, C., Boucher, N., Hébert, C., & Debonnel, G. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.01.015 · Cited by 161
Khan, A., Khan, S. R., Walens, G., Kolts, R., & Giller, E. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300059 · Cited by 158
Wheatley, D. P., Moffaert, M. V., Timmerman, L., & Kremer, C. M. E. (1998) · PubMed · Cited by 157
Furukawa, T. A., McGuire, H., & Barbui, C. (2002) · BMJ · doi:10.1136/bmj.325.7371.991 · Cited by 157
Self-citationMirtazapine Compared With Paroxetine in Major Depression
Benkert, O., Szegedi, A., & Kohnen, R. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0911 · Cited by 157
Double-Blind Comparison of Bupropion Sustained Release and Sertraline in Depressed Outpatients
Kavoussi, R. J., Segraves, R. T., Hughes, A. R., Ascher, J. A., & Johnston, J. A. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n1204 · Cited by 149
Hotopf, M. H., Hardy, R., & Lewis, G. (1997) · The British Journal of Psychiatry · doi:10.1192/bjp.170.2.120 · Cited by 148
Leinonen, E., Skarstein, J., Behnke, K., ??gren, H., & Th Helsdingen, J. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199911000-00002 · Cited by 146
Double-Blind, Randomized Comparison of Mirtazapine and Paroxetine in Elderly Depressed Patients
Schatzberg, A. F. (2002) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.10.5.541 · Cited by 146
The Selective Serotonin Reuptake Inhibitor Sertraline: Its Profile and Use in Psychiatric Disorders
MacQUEEN, G. M., Born, L., & Steiner, M. S. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00188.x · Cited by 145
Mirtazapine Orally Disintegrating Tablet Versus Sertraline: A Prospective Onset of Action Study
Behnke, K., Søgaard, J., Martin, S. D., Bäuml, J., Ravindran, A. V., Ågren, H., & Vester-Blokland, E. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000085408.08426.05 · Cited by 145
D, M. F. M., Rosenbaum, J. F., HOOG, S. L., Tepner, R. G., Kopp, J. B., & Nilsson, M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00131-7 · Cited by 140
Mirtazapine Versus Venlafaxine in Hospitalized Severely Depressed Patients With Melancholic Features
Guelfi, J. D., Ansseau, M., Timmerman, L., & Kørsgaard, S. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200108000-00010 · Cited by 138
Stahl, S. M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00957-4 · Cited by 134
Milnacipran, a new serotonin and noradrenaline reuptake inhibitor
Puech, A. J., Montgomery, S., Prost, J. F., Solles, A., & Briley, M. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199703000-00005 · Cited by 134
Coleman, C. C., Cunningham, L. A., Foster, V. J., Batey, S. R., Donahue, R. M. J., Houser, T. L., & Ascher, J. A. (1999) · Annals of Clinical Psychiatry · doi:10.1023/a:1022309428886 · Cited by 133
Industry Sponsorship and Authorship of Clinical Trials Over 20 Years
Buchkowsky, S. S., & Jewesson, P. J. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d267 · Cited by 132
Sir, A., D'Souza, R. F., Uguz, S., George, T., Vahip, S., Hopwood, M., Martin, A. J., Lam, W., & Burt, T. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1015 · Cited by 129
Montgomery, J. H., Byerly, M., Carmody, T. J., Li, B., Miller, D. R., Varghese, F. P., & Holland, R. (2004) · Controlled Clinical Trials · doi:10.1016/j.cct.2004.09.002 · Cited by 127
Lydiard, R. B., Stahl, S. M., Hertzman, M., & Harrison, W. M. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n1104 · Cited by 126
Søgaard, J., Lane, R. M., Latimer, P. R., Behnke, K., Christiansen, P. E., Nielsen, B. M., Ravindran, A. V., Reesal, R. T., & Goodwin, D. P. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300412 · Cited by 120
Zanardi, R., Franchini, L., Gasperini, M., Perez, J., & Smeraldi, E. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.12.1631 · Cited by 117
Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression
Aguglia, E., Casacchia, M., Cassano, G. B., Faravelli, C., Ferrari, G., Giordano, P., Pancheri, P., Ravizza, L., Trabucchi, M., Bolino, F., et al. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300830-00010 · Cited by 115
Probing the Safety of Medications in the Frail Elderly
Oslin, D. W., Have, T. R. T., Streim, J. E., Datto, C. J., Weintraub, D. A., DiFilippo, S. D., & Katz, I. R. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0804 · Cited by 115
Association Between Unreported Outcomes and Effect Size Estimates in Cochrane Meta-analyses
Furukawa, T. A., Watanabe, N., Omori, I. M., Montori, V. M., & Guyatt, G. H. (2007) · JAMA · doi:10.1001/jama.297.5.468-b · Cited by 115
Self-citationResponse to Phenelzine and Imipramine in Placebo Nonresponders With Atypical Depression
Quitkin, F. M. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810280035005 · Cited by 113
Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
Smith, W. T., Glaudin, V., Panagides, J., & Gilvary, E. (1990) · PubMed · Cited by 110
(1995) · PubMed · Cited by 105
ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression
Sarginson, J. E., Lazzeroni, L. C., Ryan, H. S., Ershoff, B. D., Schatzberg, A. F., & Murphy, G. M. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833b593a · Cited by 105
Fava, M., HOOG, S. L., Judge, R., Kopp, J. B., Nilsson, M., & Gonzales, J. S. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200204000-00006 · Cited by 104
Åberg‐Wistedt, A., Ågren, H., Ekselius, L., Bengtson, F., & Åkerblad, A. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200012000-00010 · Cited by 104
Malt, U. F., Robak, O. H., Madsbu, H.-P., Bakke, O., & Loeb, M. E. (1999) · BMJ · doi:10.1136/bmj.318.7192.1180 · Cited by 104
Watanabe, N., Omori, I. M., Nakagawa, A., Cipriani, A., Barbui, C., McGuire, H., Churchill, R. C., & Furukawa, T. A. (2009) · CNS Drugs · doi:10.2165/11319480-000000000-00000 · Cited by 103
Self-citationRelapse and recurrence in unipolar major depression: short-term and long-term approaches.
Thase, M. E. (1990) · PubMed · Cited by 103
Indirect comparisons: the mesh and mess of clinical trials
Ioannidis, J. P. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69615-3 · Cited by 99
Mehtonen, O. ‐., Søgaard, J., Roponen, P., Behnke, K., & Venlafaxine 631 Study Group (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0204 · Cited by 97
Thase, M. E., Nierenberg, A. A., Vrijland, P., van Oers, H. J. J., Schutte, A. J., & Simmons, J. H. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328330adb2 · Cited by 96
A double‐blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients
Hsyøerg, O. J., Maragakis, B. P., Mullin, J. M., Norum, D., Stordall, E., Ekdahl, P., Ose, E., Moksnes, K., & Sennef, C. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb10629.x · Cited by 95
Org 3770 (mirtazapine) versus trazodone: A placebo controlled trial in depressed elderly patients
Halikas, J. A. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100807 · Cited by 94
Tulen, J. H. M., Bruijn, J. A., de Man, K. J., Pepplinkhuizen, L., van den Meiracker, A. H., & Veld, A. J. M. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199604000-00006 · Cited by 93
Ekselius, L., von Knorring, L., & Eberhard, G. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199711000-00005 · Cited by 92
A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
Bremner, J. D. (1995) · PubMed · Cited by 92
Pharmacology of sertraline: a review.
Heym, J. H., & Koe, B. K. (1988) · PubMed · Cited by 88
Comparison of the Effects of Mirtazapine and Fluoxetine in Severely Depressed Patients
Versiani, M., Moreno, R. A., van Moorsel, C. J. A., Schutte, A. J., & Study, C. E. O. A. (2005) · CNS Drugs · doi:10.2165/00023210-200519020-00004 · Cited by 87
Are we going to increase the use of antidepressants up to that of benzodiazepines?
Ciuna, A., Andretta, M., Corbari, L., Levi, D., Mirandola, M., Sorio, A., & Barbui, C. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0810-8 · Cited by 87
Self-citationAntidepressant Drug Consumption and Public Health Indicators in Italy, 1955 to 2000
Guaiana, G., Andretta, M., Corbari, L., Mirandola, M., Sorio, A., D’Avanzo, B., & Barbui, C. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0612 · Cited by 86
Self-citationParoxetine versus other anti-depressive agents for depression
Purgato, M., Papola, D., Gastaldon, C., Trespidi, C., Magni, L. R., Rizzo, C., Furukawa, T. A., Watanabe, N., Cipriani, A., & Barbui, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006531.pub2 · Cited by 86
Self-citationWatanabe, N., Omori, I. M., Nakagawa, A., Cipriani, A., Barbui, C., McGuire, H., Churchill, R. C., Furukawa, T. A., & Multiple Meta-Analyses of New Generation Antidepressants (MANGA) Study Group (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0908 · Cited by 84
Self-citationLow dosage tricyclic antidepressants for depression
Furukawa, T. A., McGuire, H., & Barbui, C. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003197 · Cited by 83
Self-citationDoes Mirtazapine Have a More Rapid Onset Than SSRIs?
Quitkin, F. M., Taylor, B. P., & Kremer, C. M. E. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0509 · Cited by 83
Treatment of anxiety and depressive disorders in patients with cardiovascular disease
Davies, S., Jackson, P., Potokar, J. P., & Nutt, D. (2004) · BMJ · doi:10.1136/bmj.328.7445.939 · Cited by 79
D, M. F. M., Nierenberg, A. A., Quitkin, F. M., Zisook, S., Pearlstein, T. B., Stone, A. B., & Rosenbaum, J. F. (1997) · PubMed · Cited by 77
Moffaert, M. V., Wilde, J. D., Vereecken, A., Dierick, M., Evrard, J.-L., Wilmotte, J., & MENDLEWICZ, J. (1995) · PubMed · Cited by 77
Schüle, C., Baghai, T. C., Eser, D., Zwanzger, P., Jordan, M., Buechs, R., & Rupprecht, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0382-7 · Cited by 77
Gastpar, M., Singer, A., & Zeller, K. (2005) · Pharmacopsychiatry · doi:10.1055/s-2005-837807 · Cited by 73
Feinstein, R. E., Blumenfield, M., Orlowski, B., Frishman, W. H., & Ovanessian, S. (2006) · Cardiology in Review · doi:10.1097/01.crd.0000200977.41695.43 · Cited by 69
Outcomes into Clinical Practice
Burge, F. (1995) · Europe PMC (PubMed Central) · Cited by 67
"Wish Bias" in Antidepressant Drug Trials?
Barbui, C., Cipriani, A., Brambilla, P., & Hotopf, M. H. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000115665.45074.0d · Cited by 67
Self-citationWade, A. G., Crawford, G. M., Angus, M., Wilson, R., & Hamilton, L. (2003) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000068045.82050.00 · Cited by 66
FKBP5 polymorphisms and antidepressant response in geriatric depression
Sarginson, J. E., Lazzeroni, L. C., Ryan, H. S., Schatzberg, A. F., & Murphy, G. M. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31019 · Cited by 66
A multicentre, double‐blind, clomipramine‐controlled efficacy and safety study of org 3770
Richou, H., Ruimy, P., Charbaut, J., Delisle, J. P., Brunner, H., Patris, M., & Zivkov, M. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100403 · Cited by 65
Ventura, D., Armstrong, E. P., Skrepnek, G. H., & Erder, M. H. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x167273 · Cited by 62
Milnacipran versus other antidepressive agents for depression
Nakagawa, A., Watanabe, N., Omori, I. M., Barbui, C., Cipriani, A., McGuire, H., Churchill, R. C., & Furukawa, T. A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006529.pub2 · Cited by 61
Self-citationDoogan, D. P., & Langdon, C. J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199400920-00005 · Cited by 61
Why are so few randomized trials useful, and what can we do about it?
Zwarenstein, M., & Oxman, A. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.05.010 · Cited by 60
Amitriptyline versus other types of pharmacotherapy for depression
Guaiana, G., Barbui, C., & Hotopf, M. H. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004186 · Cited by 59
Self-citationSechter, D., Troy, S., Paternetti, S., & Boyer, P. (1999) · European Psychiatry · doi:10.1016/s0924-9338(99)80714-7 · Cited by 59
Zivkov, M., & de Jongh, G. D. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100302 · Cited by 58
Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression
Geddes, J. R., Freemantle, N., Mason, J. M., Eccles, M., & Boynton, J. R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001851.pub2 · Cited by 58
Procyshyn, R. M., Chau, A. M. T., Fortin, P. M., & Jenkins, W. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404900905 · Cited by 57
Bruijn, J. A., van den Broek, W. W., van Hulst, A. M., van den Broek, W. W., van de Wetering, B. J. M., Moleman, P., & Mulder, P. G. H. (1996) · Psychopharmacology · doi:10.1007/s002130050081 · Cited by 56
Placebo in Clinical Trials for Depression: Complexity and Necessity
Kupfer, D. J., & Frank, E. (2002) · JAMA · doi:10.1001/jama.287.14.1853 · Cited by 55
Marttila, M., Jääskeläinen, J. E., Järvi, R., Romanov, M. V., Miettinen, E., Sorri, P., Ahlfors, U. G., & Zivkov, M. (1995) · European Neuropsychopharmacology · doi:10.1016/0924-977x(95)80002-j · Cited by 54
Quednow, B. B., K�hn, K.-U., Stelzenmueller, R., Hoenig, K., Maier, W., & Wagner, M. (2003) · Psychopharmacology · doi:10.1007/s00213-004-1842-6 · Cited by 54
Fang, Y., Yuan, C., Xu, Y., Chen, J., Wu, Z., Cao, L., Yi, Z., Hong, W., Wang, Y., Jiang, K., et al. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181e7784f · Cited by 54
Nemeroff, C. B., Ninan, P. T., Ballenger, J., Lydiard, R. B., Feighner, J. P., Patterson, W. M., & Greist, J. H. (1995) · Depression · doi:10.1002/depr.3050030402 · Cited by 52
Social support networks among families of children with craniofacial anomalies.
Benson, B. A., Gross, A. M., Messer, S. C., Kellum, G. D., & al, E. (1991) · Health Psychology · doi:10.1037//0278-6133.10.4.252 · Cited by 51
Moffaert, M. V., Bartholomé, F., Cosyns, P. R., Nayer, A. R. D., & Mertens, C. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100505 · Cited by 51
Shelton, R. C., Haman, K., Rapaport, M. H., Kiev, A., Smith, W. T., Hirschfeld, R. M. A., Lydiard, R. B., Zajecka, J., & Dünner, D. L. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1102 · Cited by 51
Munizza, C., Olivieri, L., Loreto, G. D., & Dionisio, P. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x121039 · Cited by 51
Hong, C., Hu, W.-H., Chen, C.-C., Hsiao, C., Tsai, S., & Ruwe, F. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0810 · Cited by 50
St John's wort or sertraline? Randomized controlled trial in primary care.
van Gurp, G., Meterissian, G. B., Haiek, L. N., McCusker, J., & Bellavance, F. (2002) · PubMed Central · Cited by 50
Clinical and Economic Comparison of Sertraline and Fluoxetine in the Treatment of Depression
Boyer, P., Danion, J., Bisserbe, J. C., Hotton, J., & Troy, S. (1998) · PharmacoEconomics · doi:10.2165/00019053-199813010-00015 · Cited by 49
Clinical trials of antidepressant medications are producing meaningless results
Parker, G. B., Anderson, I. M., & Haddad, P. M. (2003) · The British Journal of Psychiatry · doi:10.1192/bjp.183.2.102 · Cited by 49
Barbui, C., Guaiana, G., & Hotopf, M. H. (2004) · Pharmacopsychiatry · doi:10.1055/s-2004-818985 · Cited by 49
Self-citationEfficacy of Antidepressants in the Treatment of Severe Depression: The Place of Mirtazapine
Kasper, S. F. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199704001-00003 · Cited by 49
Barbui, C., Hotopf, M. H., Freemantle, N., Boynton, J. R., Churchill, R. C., Eccles, M., Geddes, J. R., Hardy, R., Lewis, G., & Mason, J. M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002791.pub2 · Cited by 48
Self-citationBenkert, O., Szegedi, A., Philipp, M., Kohnen, R., Heinrich, C. R., Heukels, A., van der Vegte-Senden, M., Baker, R. A., Simmons, J. H., & Schutte, A. J. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000194622.99986.d6 · Cited by 48
Murphy, G. M., Kremer, C. M. E., Rodrigues, H. E., & Schatzberg, A. F. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00174-4 · Cited by 47
Sertraline Versus Fluvoxamine in the Treatment of Elderly Patients With Major Depression
Rossini, D., Serretti, A., Franchini, L., Mandelli, L., Smeraldi, E., Ronchi, D. D., & Zanardi, R. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000177548.28961.e7 · Cited by 44
Forlenza, O. V., Almeida, O. P., Stoppe, A., Hirata, E. S., & Ferreira, R. C. (2001) · International Psychogeriatrics · doi:10.1017/s1041610201007475 · Cited by 42
Kasper, S. F., Zivkov, M., Roes, K. C. B., & Pols, A. G. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(96)00394-x · Cited by 38
Moon, C. A. L., Jago, W., Wood, K., & Doogan, D. P. (1994) · Journal of Psychopharmacology · doi:10.1177/026988119400800306 · Cited by 38
Möller, H.-J., Glaser, K., Leverkus, F., & Göbel, C. (2000) · Pharmacopsychiatry · doi:10.1055/s-2000-8357 · Cited by 37
Möller, H.-J., Gallinat, J., Hegerl, U., Arató, M., Janka, Z., Pflug, B., & Bauer, H. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979323 · Cited by 35
Mullin, J. M., Lodge, A., Bennie, E. H., McCreadie, R. G., Bhatt, G. S., & Fenton, G. W. (1996) · Journal of Psychopharmacology · doi:10.1177/026988119601000310 · Cited by 35
Stahl, S. M., Mendels, J., & Schwartz, G. E. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200208000-00009 · Cited by 34
Duloxetine versus other anti-depressive agents for depression
Nosè, M., Cipriani, A., Furukawa, T. A., Omori, I. M., Churchill, R. C., McGuire, H., & Barbui, C. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006533 · Cited by 32
Self-citationScharnholz, B., Weber-Hamann, B., Lederbogen, F., Schilling, C., Gilles, M., Onken, V., Frankhauser, P., Kopf, D., & Deuschle, M. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.08.010 · Cited by 31
The impact of sertraline, desipramine, and placebo on psychomotor functioning in depression
Ravindran, A. V., Teehan, M. D., Bakish, D., Yatham, L. N., O’Reilly, R., Fernando, M. L. D., Manchanda, R., Charbonneau, Y., & Buttars, J. A. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100404 · Cited by 31
Suri, R., Altshuler, L. L., Rasgon, N. L., Calcagno, J. L., Frye, M. A., Gitlin, M. J., Hwang, S., & Zuckerbrow-Miller, J. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1209 · Cited by 31
Response to phenelzine and imipramine in placebo nonresponders with atypical depression
Quitkin, F. M., Stewart, J. W., & McGrath, P. J. (1991) · European Neuropsychopharmacology · doi:10.1016/0924-977x(91)90671-g · Cited by 30
Venlafaxine for major depression
Cipriani, A., Geddes, J. R., & Barbui, C. (2007) · BMJ · doi:10.1136/bmj.39098.457720.be · Cited by 27
Self-citationO’Connor, C. M., Glassman, A. H., & Harrison, D. J. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0311 · Cited by 25
Amini, H., Aghayan, S., Jalili, S. A., Akhondzadeh, S., Yahyazadeh, O., & Pakravannejad, M. (2005) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2004.00585.x · Cited by 24
Treatment of mood-congruent psychotic depression with imipramine
Bruijn, J. A., Moleman, P., Mulder, P. G. H., & van den Broek, W. W. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00296-2 · Cited by 23
Bruijn, J. A., Moleman, P., Mulder, P. G. H., & van den Broek, W. W. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n1203 · Cited by 21
Feiger, A. D., Flament, M. F., Boyer, P., & Gillespie, J. A. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200307000-00002 · Cited by 21
Bersani, G., Rapisarda, V., Ciani, N., Bertolino, A., & Sorge, G. (1994) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470090108 · Cited by 21
Depressed In-Patients Respond Differently to Imipramine and Mirtazapine
Bruijn, J., Moleman, P., Mulder, P., & van den Broek, W. (1999) · Pharmacopsychiatry · doi:10.1055/s-2007-979200 · Cited by 20
Effects of mirtazapine, paroxetine and their combination: a double-blind study in major depression
Debonnel, G., Gobbi, G., Turcotte, J., Boucher, N., Hébert, C., de Montigny, C., & Blier, P. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)80213-8 · Cited by 20
Szádóczky, E., & Füredi, J. (2002) · PubMed · Cited by 20
Research works printed but not linked: 16
- Khoury A Aberg Wistedt A Stain Malmgren R Effect of sertraline and paroxetine treatment on depression scores and peripheral indices of serotonergic function in major depression 11th European College of Neuropsychopharmacology Congress. Paris, France. 31st October 4th November 1998 Utrecht ECNP 1998 · doi:10.1016/s0924-977x(98)80273-3
- Behan, 1995, 5-HT reuptake inhibitors in CFS, EOS Rivista di Immunologia ed Immunofarmacologia, 15, 66
- Fournier, 1997, A double-blind comparison of sertraline and imipramine in outpatients with major depression: Acute (8 weeks) and continuation (16 weeks) treatment, Human Psychopharmacology, 12, 203, 10.1002/(SICI)1099-1077(199705/06)12:3<203::AID-HUP849>3.0.CO;2-V · doi:10.1002/(sici)1099-1077(199705/06)12:3<203::aid-hup849>3.0.co;2-v
- Hegerl, 1997, Sertraline versus amitriptyline in hospitalized patients with major depression, Pharmacopsychiatry, 30, 175
- Kamijima, 1997, A double-blind, group comparison study of sertraline by hydrochloride vs amitriptyline hydrochloride, Japanese Journal of Neuropsychopharmacology, 19, 529
- Lee, 1994, Efficacy of sertraline in dysthymia, Neuropsychopharmacology, 10, 222S
- Murasaki, 1997, Clinical evaluation of sertraline hydrochloride, a selective serotonin reuptake inhibitor for depression and depressive state-A double-blind study compared with imipramine hydrochloride, Japanese Journal of Meuropsychopharmacology, 19, 505
- Tsutsui, 1997, Clinical evaluation of sertraline hydrochloride, a selective serotonin reuptake inhibitor in the treatment of depression and depressive state: a double-blind, group comparison study of sertraline hydrochloride vs trazodone hydrochloride, Shinkeiseishinyakuri, 19, 549
- Finkel S Richter E Double-blind comparison of sertraline and nortriptyline in late-life depression 8th ECNP (European College of Neuropsychopharmacology) Congress. Venice, Italy Utrecht ECNP 1995 · doi:10.1016/0924-977x(95)90482-s
- Gonul, 1999, Selective serotonin reuptake inhibitors: discontinuation rates due to side effects, European Neuropsychopharmacology, 9, 215, 10.1016/S0924-977X(99)80132-1 · doi:10.1016/s0924-977x(99)80132-1
- Latimer PR Ravindran AV Bernatchez JP Fournier JP Gojer JA Barratt K & Buttars J A six month comparison of toleration and efficacy of sertraline and fluoxetine treatment of major depression XXth Collegium Internationale Neuro psychopharmacologicum Melbourne, Australia 1996 · doi:10.1016/0924-977x(96)87876-x
- American Psychiatric Association, 1980, Diagnostic and Statistical Manual of Mental Disorders (DSM-III)
- Guy, 1970, Manual for the ECDEU Assessment Battery.2
- National Institute for Clinical Excellence, 2004, Depression: management of depression in primary and secondary care
- World Health Organization, 1978, The Ninth Revision of the International Classification of Diseases and Related Health Problems (ICD-9)
- World Health Organization, 1982, The Tenth Revision of the International Classification of Diseases and Related Health Problems (ICD-10)
Cited by
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676
Bauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review
Edinoff, A. N., Akuly, H. A., Hanna, T. A., Ochoa, C. O., Patti, S. J., Ghaffar, Y. A., Kaye, A. D., Viswanath, O., Urits, I., Boyer, A. G., et al. (2021) · Neurology International · doi:10.3390/neurolint13030038 · Cited by 440
Atkin-Smith, G. K., Tixeira, R., Paone, S., Mathivanan, S., Collins, C., Liem, M., Goodall, K. J., Ravichandran, K. S., Hulett, M. D., & Poon, I. K. H. (2015) · Nature Communications · doi:10.1038/ncomms8439 · Cited by 398
Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
Taylor, D., Sparshatt, A., Varma, S., & Olofinjana, O. (2014) · BMJ · doi:10.1136/bmj.g1888 · Cited by 334
Metadata
- Authors
- Cipriani, A., La Ferla, T., Furukawa, T. A., Signoretti, A., Nakagawa, A., Churchill, R., McGuire, H., & Barbui, C.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2010-04-14
- Issue
- 12
- Pages
- CD006117-CD006117
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1904816587
- Cited by
- 299
- References
- 228
- FWCI
- 18.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.